T. Wooldridge

Immunity 12 years after alemtuzumab in RA: CD5⁺ B-cell depletion, thymus-dependent T-cell reconstitution and normal vaccine responses.

J. Isaacs, C. Hilkens, A. Anderson, 2012, Rheumatology.

Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.

D. Weisenburger, J. Armitage, W. Sanger, 1988, Cancer research.

Penile verrucous carcinoma: a clinicopathologic, human papillomavirus typing and flow cytometric analysis.

M. Stoler, S. Johansson, G. Farrow, 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics.

D. Weisenburger, J. Armitage, M. Bast, 1995, Cancer genetics and cytogenetics.

Proliferative fraction and DNA content are lower in B-cell non-Hodgkin's lymphomas with the t(14;18).

D. Weisenburger, J. Armitage, M. Bast, 1995, Leukemia & lymphoma.

Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.

D. Symmons, J. Isaacs, G. Hale, 2008, Arthritis and rheumatism.

Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate.

J. Harper, T. Wooldridge, D. Patton, 1996, Bone marrow transplantation.

Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors.

S. Radio, J. Linder, T. Wooldridge, 1988, Human pathology.

Is Parathyroid Carcinoma Indeed a Lethal Disease?

J. Lovato, S. Bergman, N. Perrier, 2005, Annals of Surgical Oncology.

Low proliferative activity is associated with a favorable prognosis in peripheral T-cell lymphoma.

D. Weisenburger, J. Armitage, M. Bast, 1990, Cancer research.